C.R. Bard, Inc. (BCR) Stake Boosted by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in C.R. Bard, Inc. (NYSE:BCR) by 26.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,343 shares of the medical instruments supplier’s stock after buying an additional 1,128 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in C.R. Bard were worth $1,328,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. Mizuho Trust & Banking Co. Ltd. boosted its stake in shares of C.R. Bard by 7.2% in the third quarter. Mizuho Trust & Banking Co. Ltd. now owns 129,014 shares of the medical instruments supplier’s stock worth $28,935,000 after buying an additional 8,650 shares during the last quarter. Cardinal Capital Management boosted its stake in shares of C.R. Bard by 1.3% in the third quarter. Cardinal Capital Management now owns 23,280 shares of the medical instruments supplier’s stock worth $5,221,000 after buying an additional 308 shares during the last quarter. Carderock Capital Management Inc. boosted its stake in shares of C.R. Bard by 48.9% in the third quarter. Carderock Capital Management Inc. now owns 18,175 shares of the medical instruments supplier’s stock worth $4,076,000 after buying an additional 5,967 shares during the last quarter. GVO Asset Management Ltd boosted its stake in shares of C.R. Bard by 293.5% in the third quarter. GVO Asset Management Ltd now owns 47,165 shares of the medical instruments supplier’s stock worth $10,578,000 after buying an additional 35,180 shares during the last quarter. Finally, Signature Estate & Investment Advisors LLC boosted its stake in shares of C.R. Bard by 80.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 1,375 shares of the medical instruments supplier’s stock worth $308,000 after buying an additional 614 shares during the last quarter. Institutional investors and hedge funds own 88.32% of the company’s stock.

Institutional Ownership by Quarter for C.R. Bard (NYSE:BCR)

C.R. Bard, Inc. (NYSE:BCR) traded down 0.12% during midday trading on Friday, hitting $313.56. The company had a trading volume of 728,015 shares. The company has a market cap of $22.71 billion, a P/E ratio of 39.91 and a beta of 0.64. The company’s 50 day moving average is $309.48 and its 200-day moving average is $257.26. C.R. Bard, Inc. has a one year low of $203.63 and a one year high of $315.29.

C.R. Bard (NYSE:BCR) last released its earnings results on Sunday, April 23rd. The medical instruments supplier reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.22. C.R. Bard had a return on equity of 48.72% and a net margin of 15.70%. The business had revenue of $938.80 million for the quarter, compared to analyst estimates of $916.15 million. During the same quarter in the prior year, the company posted $2.34 earnings per share. C.R. Bard’s revenue was up 7.5% on a year-over-year basis. On average, equities analysts predict that C.R. Bard, Inc. will post $11.78 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, August 4th. Investors of record on Monday, July 24th will be issued a dividend of $0.26 per share. The ex-dividend date of this dividend is Thursday, July 20th. This represents a $1.04 annualized dividend and a yield of 0.33%. C.R. Bard’s payout ratio is presently 13.21%.

TRADEMARK VIOLATION WARNING: This report was first published by BBNS and is owned by of BBNS. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://baseballnewssource.com/markets/c-r-bard-inc-bcr-shares-bought-by-commonwealth-of-pennsylvania-public-school-empls-retrmt-sys-updated-updated/850355.html.

Several equities analysts recently commented on BCR shares. Jefferies Group LLC reissued a “hold” rating and set a $237.00 price target on shares of C.R. Bard in a research report on Monday, March 27th. Zacks Investment Research lowered C.R. Bard from a “buy” rating to a “hold” rating in a research report on Monday, June 12th. Morgan Stanley lowered C.R. Bard from an “overweight” rating to an “equal weight” rating in a research report on Monday, April 24th. Raymond James Financial, Inc. reissued a “market perform” rating and set a $265.00 price target on shares of C.R. Bard in a research report on Tuesday, April 25th. Finally, BMO Capital Markets lowered C.R. Bard from an “outperform” rating to a “market perform” rating and set a $245.00 price target on the stock. in a research report on Tuesday, April 25th. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $265.62.

In related news, VP Frank Lupisella, Jr. sold 3,622 shares of the company’s stock in a transaction dated Monday, April 24th. The stock was sold at an average price of $304.00, for a total transaction of $1,101,088.00. Following the sale, the vice president now owns 10,139 shares in the company, valued at $3,082,256. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.80% of the company’s stock.

C.R. Bard Company Profile

C. R. Bard, Inc (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis.

Receive News & Ratings for C.R. Bard Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C.R. Bard Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.